Warning Letter — kadobarofficial.com
The FDA Center for Tobacco Products issued a warning letter to kadobarofficial.com on May 1, 2026, regarding the marketing and sale of unauthorized tobacco products.
This affects the operator of kadobarofficial.com, as well as retailers and distributors involved in the sale of electronic nicotine delivery systems (ENDS).
This enforcement action indicates continued FDA scrutiny of online retailers selling ENDS products without the required marketing authorizations. It suggests that the CTP is maintaining active surveillance of digital storefronts to ensure compliance with the Tobacco Control Act. Non-compliance may lead to further administrative actions, including civil money penalties or permanent injunctions.
Retailers and distributors should immediately audit their product portfolios to ensure all ENDS products have received necessary PMTA marketing authorizations. Regulatory teams must monitor the CTP database for newly issued warning letters to adjust procurement and distribution channels accordingly.
FDA Warning Letter issued to: kadobarofficial.com. 05/01/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kadobarofficialcom-729131-05012026
Open in openFDA / FDA.gov